Identification of Genomic Predictors of Adverse Events After Cardiac Surgery



Status:Recruiting
Conditions:Atrial Fibrillation, Other Indications, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases, Other
Healthy:No
Age Range:20 - 90
Updated:9/22/2018
Start Date:August 2000
End Date:August 2030

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
This study aims to identify genetic causes of adverse events after cardiac surgery, such as
atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.

Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute
are eligible to participate.

This study aims to identify genetic causes of adverse events after cardiac surgery, such as
atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.

Inclusion Criteria:

- Undergoing heart surgery

- Willing to provide consent

Exclusion Criteria:

- Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
We found this trial at
3
sites
U.T. Southwestern Medical Center
2201 Inwood Rd
Dallas, Texas 75235
(214) 645-8300
Principal Investigator: Amanda A Fox, MD
Phone: 214-648-8018
U.T. Southwestern Medical Center The story of UT Southwestern Medical Center is one of commitment...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Brigham and Women's Hosp
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Principal Investigator: Simon C Body, MBChB, MPH
Phone: 617-732-7330
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials
Department Texas Heart Institute at St. Luke's Episcopal Hospital
Houston, Texas 77225
Principal Investigator: Charles D Collard, MD
Phone: 832-355-4615
?
mi
from
Houston, TX
Click here to add this to my saved trials